The Relationship Between Peripheral Arterial Disease and Mitochondrial Respiratory Capacity
NCT ID: NCT02434783
Last Updated: 2016-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2015-05-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will elucidate whether there is a relation between clinical variables of the different levels of arterial insufficiency in peripheral arterial disease and mitochondrial respiratory capacity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Abdominal Adiposity and Muscle Mitochondrial Functions
NCT00446745
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
NCT01301235
Effects of Different Protocols of Physical Training on Levels of Muscle Strength and Functional Capacity
NCT03092336
Study of Muscle Repair Following Exercise in Young and Elderly People
NCT02174692
Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age
NCT04405180
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1st level of arterial insufficiency
asymptomatic PAD patients
No interventions assigned to this group
2nd level of arterial insufficiency
Intermittent claudication patients
No interventions assigned to this group
3rd level of arterial insufficiency
Critical limb ischemia patients
No interventions assigned to this group
No arterial insufficiency
Healthy individuals (control)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Warfarin or heparin usage
* Underwent a vascular intervention in the last 6 months
* Active cancer, renal- or liver disease
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Øyvind Rognmo
Role: STUDY_DIRECTOR
Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Circulation and Medical Imaging
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/204
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.